Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Safety and Immunogenicity Study of Aleph Inactivated Split Influenza Vaccine

NCT01758185 is registered in ClinicalTrials.gov with Beijing Center for Disease Control and Prevention as lead sponsor.

NCT NCT01758185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01758185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Safety and Immunogenicity Study of Aleph Inactivated Split Influenza Vaccine
Lead sponsor
Beijing Center for Disease Control and Prevention
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2011
Completion date
December 31, 2012
Enrollment
3,308 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy